GBI Research’s latest report “Contract Research Organization Market: Global Deals and Operational Strategies” discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key players in the recent years have been listed. A heatmap analysis of the key companies was done based on their firm utilization and capital management. SWOT analysis and profiles are given for the key companies in the market.
Companies mentioned in the report are Quintiles, Covance, Parexel, Catalent, ICON, PRA Health, Charles River, INC Research, WuXi PharmaTech, CMIC Holdings, EPS Corporation, Recipharm, Novotech, Laboratory Corporation of America Holdings, Consort Medical, Meiji Seika, Eurofins Scientific, Simbec Research, Hangzhou Tigermed, MPI Research, Sun Pharma, Noble Life Sciences, Chiltern International, BioPharma, Carlina, Euprotech, Protagen, Assign, Aurigon, Celonic and PharmaLex, Cromos Pharma, Avillion, Pfizer, Sanofi, Harlan Labs, Almac Group, Jubilant Biosys
Scope
The scope of the report includes:
Overview of key reasons behind outsourcing, outsourcing service models
Examples of operational strategies
Global deals analysis by type and value
Major acquisitions and partnerships
Regional analysis of North America, Europe, Asia-Pacific and Emerging markets
Company benchmarking based on heatmap analysis
Vendor positioning
SWOT analysis and profiles of key players
Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/286562
Reasons To Buy
The report will enhance your decision-making capability by allowing you to:
Identify the top players in the CRO market, financial revenues and key services offered
Analyze the key geographies that are lucrative markets for deal making, market-entry and market expansion strategies
Analyze the trends in acquisitions, licensing and other type of deals and explore potential investment opportunities
Understand the operational strategies of key players
